Carbylan Therapeutics, Inc.
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2015-03-053/5/15 | New | $4,000,000 | $4,000,000 | Debt Only | 06b | SEC linkSEC |
| 2014-10-1410/14/14 | New | $5,000,000 | $5,000,000 | Debt Only | 06b | SEC linkSEC |
| 2013-01-031/3/13 | New | $5,999,999 | $5,999,999 | Equity Only | 06 | SEC linkSEC |
| 2005-12-2912/29/05 | Paper Filing | Unknown | Unknown | Other | Not AvailableN/A | |
| 2005-12-2912/29/05 | Paper Filing | Unknown | Unknown | Other | Not AvailableN/A |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Steven L. Basta | Director |
| Albert Cha | Director |
| David Clapper | Director |
| George Daniloff | Director, Executive |
| Roxanne Dubois | Executive |
| Chris Ehrlich | Director |
| David M. Gravett | Executive |
| Keith A. Katkin | Director |
| Hayley Lewis | Executive |
| Marcee M. Maroney | Executive |
| Guy P. Nohra | Director |
| David M. Renzi | Director, Executive |
| Timothy L. Trapp | Executive |
| Edward W. Unkart | Director |
| Mark Weeks | Executive |
| T. Michael White | Executive |
| Reza Zadno | Director |
Industry: Other Health Care (See others in industry)
Address:
3181 Porter Drive
Palo Alto, CA, 94304
Phone: 650-855-6777
Palo Alto, CA, 94304
Phone: 650-855-6777